Risk Of Developing Liver Cancer After HCV Treatment

▼
Showing posts with label Canada. Show all posts
Showing posts with label Canada. Show all posts
Thursday, February 21, 2019

MAVIRET - AbbVie reaches an agreement with the pan-Canadian For HCV Drug

›
AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for its hepatitis C treatment MAVIRET™ Feb. 21, 2019, 1...
Monday, October 29, 2018

What's Up Doc?: Hepatitis C, a killer that can be stopped

›
What's Up Doc?: Hepatitis C, a killer that can be stopped By Dr. Malavika Varma with Dr. Aravind Ganesh Hepatitis C (HepC) is an...
Monday, June 4, 2018

Updated Guidelines - Hepatitis C testing recommended for Canadians born between 1945 and 1975

›
Podcast In this podcast, Dr. Hemant Shah and Dr. Jordan Feld discuss a clinical practice guideline from the Canadian Association for the S...
Monday, May 28, 2018

Canada launches call for proposals under its Harm Reduction Fund

›
Government of Canada launches call for proposals under its Harm Reduction Fund Reducing the risk of HIV, hepatitis C and other blood-borne i...
Tuesday, March 27, 2018

Methadone maintenance therapy and having access to regular physician care regarding HCV among people who inject drugs

›
The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs Lianp...
Monday, March 19, 2018

Prescription Drugs : The Costco Kickbacks

›
Prescription Drugs : The Costco Kickbacks Secret audio tapes and an exclusive television interview with an industry whistleblower reveal a...
Monday, March 5, 2018

Provincial funding for hepatitis C drugs a game changer, health professionals say

›
CBC News Provincial funding for hepatitis C drugs a game changer, health professionals say Changes spurred by development of minimally inv...
Tuesday, February 6, 2018

The Canadian Treatment Action Council Launches Campaign to End Hepatitis C in Canada

›
CTAC Launches Campaign to End Hepatitis C in Canada TORONTO, Feb. 6, 2018 /CNW/ - The Canadian Treatment Action Council (CTAC) has publis...

AbbVie receives a positive recommendation from the CADTH Canadian Drug Expert Committee for MAVIRET™

›
AbbVie receives a positive recommendation from the CADTH Canadian Drug Expert Committee for MAVIRET™ - an oral therapy for the treatment of...
Wednesday, January 24, 2018

Population-based estimate of hepatitis C virus prevalence in Ontario, Canada

›
PLoS One. 2018 Population-based estimate of hepatitis C virus prevalence in Ontario, Canada Shelly Bolotin , Jordan J. Feld, Gary Garb...
Wednesday, November 15, 2017

Podcast: What it will take for hepatitis C to be cured in Canada

›
AMI Podcast November 13, 2017 episode 2017 World Hepatitis Summit Hepatitis C in Canada   Dr. Jordan Feld from the Toronto Centre for L...
Saturday, November 11, 2017

Hepatitis C Virus (HCV) diagnosis, epidemiology and access to treatment in a UK cohort

›
New Results Hepatitis C Virus (HCV) diagnosis, epidemiology and access to treatment in a UK cohort Emily Adland , Gerald Jesuthasan , L...
Friday, November 3, 2017

Hepatitis C is a huge public health problem in Canada

›
Hepatitis C could be eliminated in Canada, but drug prices, screening barriers stand in the way By Nicole Ireland, CBC News Posted: Nov 0...
Saturday, September 23, 2017

Gilead Receives Approval in Canada for Expanded Indication of EPCLUSA® for Chronic Hepatitis C in Patients Co-Infected with HIV

›
Gilead Receives Approval in Canada for Expanded Indication of EPCLUSA® (Sofosbuvir/Velpatasvir) for the Treatment of Chronic Hepatitis C in ...
Thursday, August 31, 2017

Health and economic effects of screening for hepatitis C in Canada

›
Recommended Reading April 24, 2017 New hepatitis C screening guidelines will lead to avoidable deaths and soaring costs to health care sy...
Thursday, August 17, 2017

Gilead's VOSEVI HCV Regimen for Re-Treatment Receives Health Canada Approval

›
Gilead Receives Health Canada Approval for the First Once-Daily, Single Tablet HCV Regimen for Re-Treatment August 17, 2017 Deb Schmitz ...

AbbVie's MAVIRET Approved by Health Canada

›
AbbVie's MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes MAVIRET is the first a...
Monday, April 24, 2017

New hepatitis C screening guidelines will lead to avoidable deaths and soaring costs to health care system

›
New hepatitis C screening guidelines will lead to avoidable deaths and soaring costs to health care system Reliance on risk-based testi...

Hepatitis C: New Canadian guidelines recommend against screening low-risk adults

›
New hepatitis C screening guidelines will lead to avoidable deaths and soaring costs to health care system New hepatitis C screening guide...
Monday, April 3, 2017

EPCLUSA™ - Alberta Also Broadens Access for Patients with Less Advanced Disease Who Have Other Health Conditions

›
-- Alberta Also Broadens Access for Patients with Less Advanced Disease Who Have Other Health Conditions -- MISSISSAUGA, ON , April 3, 201...